Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Hydrochlorothiazide (12.5mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic, Cardiology, Hypertension/ Blood Pressure
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Hyrozide 12.5 Tablet contains Hydrochlorothiazide 12.5 mg, a thiazide diuretic used to manage high blood pressure and fluid retention (edema) associated with congestive heart failure, kidney disorders, or liver disease.
Hydrochlorothiazide helps by removing excess water and sodium from the body, reducing blood pressure and swelling. It is commonly prescribed as monotherapy or in combination with other antihypertensive agents.
This tablet belongs to the cardiology and nephrology segment and is regularly prescribed in cardiology OPDs, clinics, and hospital setups. It is recognized as an essential hypertension control medicine and maintains strong recurring demand in pharmacies.
For PCD franchise distributors, institutional buyers, and third-party manufacturers, Hyrozide 12.5 is a value-driven portfolio addition with strong market acceptance and continuous prescription support across India.
Some individuals may experience increased urination, dizziness, headache, electrolyte imbalance (such as low potassium or sodium), dry mouth, or weakness. Rare but serious reactions may include dehydration, gout flare-ups, or kidney function changes. Seek medical advice if symptoms persist or worsen.
Hyrozide 12.5 Tablet is commonly used in the management of hypertension (high blood pressure) and is also prescribed to treat edema associated with conditions like congestive heart failure, liver cirrhosis, and kidney disorders. It helps in maintaining long-term blood pressure control and supporting cardiovascular health.
Hyrozide 12.5 Tablet should be taken exactly as directed by a healthcare professional. Regular monitoring of electrolytes, kidney function, and blood pressure is advised during treatment. Inform your doctor if you have diabetes, gout, kidney disease, or are taking other antihypertensive medicines.
Store Hyrozide 12.5 Tablet in a cool, dry place below 25°C, away from direct light and moisture. Keep out of reach of children.
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Rosuvastatin 20mg + Clopidogrel 75mg Tablet
Composition : Prazosin (2.5mg) Sustained Release Tablet
Composition : Prazosin (5 mg) Sustained Release
Composition : Metoprolol Succinate 100mg PR Tablet
Composition : Metoprolol 12.5 XL Tablet
Composition : Metoprolol Succinate (25mg) ER Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Hydrochlorothiazide 12.5 mg Tablet has strong demand in the cardiology and hypertension management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on chronic care and cardiovascular portfolios.
Medical distributors and agencies can benefit from consistent demand for management of high blood pressure (hypertension), mild edema (fluid retention), heart-related fluid overload, and kidney-related water imbalance conditions. Hydrochlorothiazide I.P. 12.5 mg is a thiazide diuretic that helps reduce sodium and water retention Commonly used as a first-line or combination therapy in hypertension treatment This strengthens a reliable cardiology and chronic-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Hydrochlorothiazide 12.5 mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong physician prescriptions, long-term chronic therapy demand, high repeat sales, reliable supply chain support, and good margins in antihypertensive medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.